Cognitive enhancing effect of the fermented Gumiganghwal-tang on scopolamine-induced memory impairment in mice

Nutritional Neuroscience

Volumn 19, Issue 3, 2016, Pages 125-130

  Weon, Jin Bae ^a   Lee, Jiwoo ^a   Eom, Min Rye ^a   Jung, Youn Sik ^a   Ma, Choong Je ^a  

^a Kangwon National University   (South Korea)

Author keywords

Acetylcholinesterase; Cognitive enhancing effect; Fermented Gumiganghwal tang; Morris water maze test; Passive avoidance test

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; SCOPOLAMINE; ACHE PROTEIN, MOUSE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INDAN DERIVATIVE; KUMI-KYOKATSU-TO; MUSCARINIC RECEPTOR BLOCKING AGENT; NERVE PROTEIN; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE; PLANT EXTRACT; SCOPOLAMINE BROMIDE;

AMNESIA; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ESCAPE BEHAVIOR; HERBAL MEDICINE; HIPPOCAMPUS; MEMORY; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; SWIMMING; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FERMENTATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MAZE TEST; MEMORY DISORDERS; METABOLISM; NERVE CELL; SOUTH KOREA;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FERMENTATION; GPI-LINKED PROTEINS; HIPPOCAMPUS; INDANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE, INBRED ICR; MUSCARINIC ANTAGONISTS; NERVE TISSUE PROTEINS; NEURONS; NOOTROPIC AGENTS; PIPERIDINES; PLANT EXTRACTS; REPUBLIC OF KOREA; SCOPOLAMINE HYDROBROMIDE;

EID: 84962048228     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000152     Document Type: Article

References (24)

1. Moon YH, Go JJ, Park JY. The anti-inflammatory and analgesic activities of Gumiganghwaltang. Kor J Pharmacogn 1999;30: 18–24.
2. Shin IS, Kim JH, Ha HK, Sea CS, Lee MY, Lee HY, et al. Acute toxicity study on Gumiganghwal-tang (Jiuweiqianghuo-tang) in sprague-dawley rats. Kor J Orient Med Prescript 2010;18:79–85.
3. Shin IS, Seo CS, Lee MY, Ha HK. In vitro and in vivo evaluation of the genotoxicity of Gumiganghwal-tang, a traditional herbal prescription. J Ethnopharmacol 2012;141:350–6.
4. Kim SJ, Jeong HJ, Moon PD, Lee KM, Lee HB, Jung HJ, et al. Anti-inflammatory activity of Gumiganghwaltang through the inhibition of nuclear factor-κB activation in peritoneal macrophages. Biol Pharm Bull 2005;28(2):233–7.
5. Lee MY, Seo CS, Shin IS, Ha H, Kim JH, Cho JW, et al. Toxicological evaluation of Gumiganghwaltang aqueous extract in Crl:CD (SD) rats: 13 weeks oral gavage studies. Regul Toxicol Pharmacol 2012;62(3):553–60.
6. Yun BR, Weon JB, Lee J, Eom MR, Ma CJ. Neuroprotective effect of the fermented Gumiganghwal-tang. J Biosci Bioeng 2014;118(2):235–8.
7. Crapper DR, DeBoni U. Brain aging and Alzheimer’s disease. Can Psychiatr Assoc J 1978;23(4):229–33.
8. Swerdlow RH. Pathogenesis of Alzheimer’s disease. Clin Interv Aging 2007;2(3):347–59.
9. Jovanović Z. Mechanisms of neurodegeneration in Alzheimer’s disease. Med Pregl 2012;65(7–8):301–7.
10. Flood JF, Cherkin A. Scopolamine effects on memory retention in mice: a model of dementia? Behav Neural Biol 1986;45: 169–84.
11. Morris R. Developments of water-maze procedure for studying spatial learning in rats. J Neurosci Methods 1984;11: 47–60.
12. Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. A new and rapid colorimetricdetermination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
13. Friedman E, Lerer B, Kuster J. Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning. Pharmacol Biochem Behav 1983;19(2):309–12.
14. Collerton D. Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience 1986;19:1–28.
15. Lewis PR, Shute CCD. Confirmation from choline acetylase analyses of a massive cholinergic innervation to the hippocampus. J Physiol 1964;172:9–10.
16. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 1995;21:285–300.
17. Alfano DP, Petit TL, LeBoutillier JC. Development and plasticity of the hippocampal-cholinergic system in normal and early lead exposed rats. Brain Res 1983;312(1):117–24.
18. McGleenon BM, Dynan KB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer’s disease. Br J Clin Pharmacol 1999;48: 471–80.
19. Ballard CG. Advances in the treatment of Alzheimer’s disease: benefits of dual cholinesterase inhibition. Eur Neurol 2002;47: 64–70.
20. Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 1998;28:944–9.
21. Agrawal R, Tyagi E, Saxena G, Nath C. Cholinergic influence on memory stages: a study on scopolamine amnesic mice. Indian J Pharmacol 2011;41(4):192–6.
22. Kim S, Kim DH, Choi JJ, Lee JG, Lee CH, Park SJ, et al. Forsythiaside, a constituent of the fruits of forsythia suspense, Ameliorates scopolamine-induced memory impairment in mice. Biomol Ther 2009;17(3):249–55.
23. Hwang YK, Jinhua M, Choi BR, Cui CA, Jeon WK, Kim H, et al. Effects of Scutellaria baicalensis on chronic cerebral hypoperfusion-induced memory impairments and chronic lipopolysaccharide infusion-induced memory impairments. J Ethnopharmacol 2011;137(1):681–9.
24. Lee B, Shim I, Lee H, Hahm DH. Rehmannia glutinosa ameliorates scopolamine-induced learning and memory impairment in rats. J Microbiol Biotechnol 2011;21(8):874–83.